Literature DB >> 19135270

Is direct method of low density lipoprotein cholesterol measurement appropriate for targeting lipid lowering therapy?

Murat Can, Serefden Acikgoz, Gorkem Mungan, Ebru Ugurbas, Handan Ankarali, Vildan Sumbuloglu, Selda Demirtas, Levent Karaca.   

Abstract

OBJECTIVES: The aim of this study was to compare the Friedewald Formula with direct homogeneous low density lipoprotein cholesterol (LDL-C) assay for the detection of LDL-C levels.
METHODS: Fasting serum samples were obtained for lipid analysis from 1001 patients. Total cholesterol (TC) and triglyceride (TG) levels were measured with enzymatic methods and the measurements of high density lipoprotein cholesterol (HDL-C) and LDL-C levels were detected using direct methods.
RESULTS: The mean levels of serum TC, TG, HDL-C and LDL-C were detected with in the reference range. The LDL-C estimated by the Friedewald formula was significantly correlated (P<0.01) with the direct method but there was a negative bias among them.
CONCLUSION: Laboratories cannot use direct method as a substitute for Friedewald formula because direct method has not been standardized in large populations and increase cholesterol assay costs. Copyright 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135270     DOI: 10.1016/j.ijcard.2008.11.141

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Effects of USF1 SNPs and SNP-Environment Interactions on Serum Lipid Profiles and the Risk of Early-Onset Coronary Artery Disease in the Chinese Population.

Authors:  Peng-Fei Zheng; Lu-Zhu Chen; Hong-Wei Pan; Peng Liu; Zhao-Fen Zheng
Journal:  Front Cardiovasc Med       Date:  2022-06-15

2.  Is Friedewald formula a good estimation for low density lipoprotein level in Iranian population?

Authors:  Maryam Boshtam; Mohammad Arash Ramezani; Gholamali Naderi; Nizal Sarrafzadegan
Journal:  J Res Med Sci       Date:  2012-06       Impact factor: 1.852

3.  Serum albumin levels and their correlates among individuals with motor disorders at five institutions in Japan.

Authors:  Hiroko Ohwada; Takeo Nakayama; Yuki Kanaya; Yuki Tanaka
Journal:  Nutr Res Pract       Date:  2017-01-26       Impact factor: 1.926

4.  Correlations between Direct and Calculated Low-Density Lipoprotein Cholesterol Measurements in Children and Adolescents.

Authors:  Sultan Alouffi; Mohd Wajid Ali Khan; Nawaf Alotabi; Amal Alsuggyair; Ikram Alhassan; Ibrahim Al Alwan; Esam Al Banyan; Yasmin A Al-Twaijri; Hani Tamim; Fahad Al-Hussein; Salih Aljasser; Hanan Alfwaz; Waleed Tamimi
Journal:  J Clin Lab Anal       Date:  2020-03-03       Impact factor: 2.352

5.  Weighted gene co-expression network analysis to identify key modules and hub genes related to hyperlipidaemia.

Authors:  Fu-Jun Liao; Peng-Fei Zheng; Hong-Wei Pan; Wei Li; Yao-Zong Guan
Journal:  Nutr Metab (Lond)       Date:  2021-03-04       Impact factor: 4.169

6.  Measuring Low Density Lipoprotein Cholesterol: Comparison of Direct Measurement by HiSens Reagents and Friedewald Estimation.

Authors:  So-Young Lee; Sang-Keun Hahm; Jin-A Park; Sung-Kyu Choi; Ji-Young Yoon; Seon-Hee Choi; Kyoung-So Jeon
Journal:  Korean J Fam Med       Date:  2015-07-17

7.  Comparison of various formulae for estimating low-density lipoprotein cholesterol by a combination of ages and genders in Taiwanese adults.

Authors:  Chung-Huang Tsai; Hsin-Hung Wu; Shao-Jen Weng
Journal:  BMC Cardiovasc Disord       Date:  2014-09-02       Impact factor: 2.298

8.  Association of the variants and haplotypes in the DOCK7, PCSK9 and GALNT2 genes and the risk of hyperlipidaemia.

Authors:  Tao Guo; Rui-Xing Yin; Wei-Xiong Lin; Wei Wang; Feng Huang; Shang-Ling Pan
Journal:  J Cell Mol Med       Date:  2015-10-23       Impact factor: 5.310

9.  SYNE1-QK1 SNPs, G × G and G × E interactions on the risk of hyperlipidaemia.

Authors:  Peng-Fei Zheng; Rui-Xing Yin; Chun-Xiao Liu; Guo-Xiong Deng; Yao-Zong Guan; Bi-Liu Wei
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.